scholarly journals Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers — United States, 2010–2015

2016 ◽  
Vol 65 (29) ◽  
pp. 748-749 ◽  
Author(s):  
Mehruba Anwar ◽  
Royal Law ◽  
Josh Schier
2010 ◽  
Vol 28 (7) ◽  
pp. 780-785 ◽  
Author(s):  
Henry A. Spiller ◽  
George M. Bosse ◽  
Mark L. Ryan
Keyword(s):  

2018 ◽  
Vol 56 (11) ◽  
pp. 1107-1114 ◽  
Author(s):  
S. L. Calcaterra ◽  
S. G. Severtson ◽  
G. E. Bau ◽  
Z. R. Margolin ◽  
B. Bucher-Bartelson ◽  
...  

2015 ◽  
Vol 35 (7) ◽  
pp. 705-712 ◽  
Author(s):  
MB Forrester

Poison centers advance knowledge in the field of toxicology through publication in peer-review journals. This investigation describes the pattern of poison center-related publications. Cases were poison center-related research published in peer-review journals during 1995–2014. These were identified through searching the PubMed database, reviewing the tables of contents of selected toxicology journals, and reviewing abstracts of various national and international meetings. The following variables for each publication were identified: year of publication, journal, type of publication (meeting abstract vs. other, i.e. full article or letter to the editor), and the country(ies) of the poison center(s) included in the research. Of the 3147 total publications, 62.1% were meeting abstracts. There were 263 publications in 1995–1999, 536 in 2000–2004, 999 in 2005–2009, and 1349 in 2010–2014. The publications were in 234 different journals. The journals in which the highest number of research was published were Clinical Toxicology (69.7%), Journal of Medical Toxicology (2.2%), and Veterinary and Human Toxicology (2.1%). The research was reported from 62 different countries. The countries with the highest number of publications were the United States (67.9%), United Kingdom (6.5%), Germany (3.9%), France (2.5%), and Italy (2.4%). The number of publications increased greatly over the 20 years. Although the publications were in a large number of journals, a high proportion of the publications were in one journal. While the research came from a large number of countries, the preponderance came from the United States.


2021 ◽  
Vol 8 (12) ◽  
pp. 689-691
Author(s):  
H. Reid Zweifel ◽  
Jonathan Browne ◽  
Jeffrey M Levine

Objective: Drug overdose deaths have risen precipitously over the past two years in the United States. Polysubstance overdose with opiates and amphetamines have been of particular concern. Kratom (Mitragyna speciosa) is an unregulated widely available herb with both stimulant and opiate μ-receptor activity. Studies suggest that its use is quickly increasing. Case: We describe a patient who presented to a psychiatric hospital with a mixed toxic syndrome due to chronic kratom and prescribed SSRI use compounded by acute intake of methamphetamine. The patient displayed psychosis, tremulousness, myoclonus, and extreme anxiety. Her clinical picture was consistent with both serotonin syndrome and opiate withdrawal. Conclusion: We call attention to this case because polysubstance overdoses are common, and kratom is widely available. Complex toxic presentations that involve kratom are likely to be increasingly encountered.


2020 ◽  
Vol 16 (5) ◽  
pp. 391-394
Author(s):  
Seth Kalin, MD ◽  
Salaahuddin Dakhlalla, MD ◽  
Saurabh Bhardwaj, MD

Kratom (Mitragyna speciosa) is a plant extract that exhibits opioid agonistic activity at the μ-opioid receptor. The use of this substance has increased recently due to widespread local availability across the United States (US), primarily at gas stations. Repeated kratom use has been shown to have major adverse effects leading to physiological dependence and addiction similar to other opioids. We used a novel contingency management (CM) program utilizing nonmonetary reinforcers along with medication-assisted treatment (MAT) using buprenorphine in an office-based setting to treat kratom use disorder in two cases. MAT with buprenorphine in a CM-based setting was found to be an effective strategy for treating kratom use disorder.


2013 ◽  
Vol 51 (10) ◽  
pp. 941-948 ◽  
Author(s):  
Suzanne Doyon ◽  
Wendy Klein-Schwartz ◽  
Samantha Lee ◽  
Michael C. Beuhler
Keyword(s):  

2020 ◽  
pp. 1-8
Author(s):  
James B. Leonard ◽  
Faisal S. Minhaj ◽  
Wendy Klein-Schwartz
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document